Emcure partners Roche to distribute kidney transplant and anemia therapies in India

Emcure Pharmaceuticals signs a distribution deal with Roche to supply CellCept, Mircera, and Neorecormon for nephrology and transplant care in India, effective April 1, 2026.

Leave a Reply

Your email address will not be published. Required fields are marked *